|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2300074113 |
|
最近更新日期: Date of Last Refreshed on: |
2023-07-31 11:02:28 |
|
注册时间: Date of Registration: |
2023-07-31 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
经皮等离子椎间盘减压术通过下颈椎入路改善上肢根性症状和颈源性头痛:一项回顾性队列研究 |
|
Public title: |
Percutaneous plasma disc decompression improves upper extremity radicular symptoms and cervicogenic headaches through a lower cervical approach: A retrospective Cohort study |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
评估等离子椎间盘减压术及颈神经射频术治疗神经根型颈椎病的有效性和安全性:一项回顾性研究 |
|
Scientific title: |
Evaluation of the effectiveness and safety of percutaneous plasma disc decompression and pulse radiofrequency in the treatment of cervical spondylotic radiculopathy: a retrospective study |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
孔舒祎 |
研究负责人: |
孔舒祎 |
|
Applicant: |
Shuyi Kong |
Study leader: |
Shuyi Kong |
|
申请注册联系人电话: Applicant telephone: |
+86 199 1654 5076 |
研究负责人电话:
Study leader's |
+86 199 1654 5076 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
1273961916@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
1273961916@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
上海市静安区芷江中路274号 |
研究负责人通讯地址: |
上海市静安区芷江中路274号 |
|
Applicant address: |
274 Zhijiang Middle Road, Jing'an District, Shanghai, China |
Study leader's address: |
274 Zhijiang Middle Road, Jing'an District, Shanghai, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
上海市中医医院 |
||
|
Applicant's institution: |
Shanghai Municipal Hospital of Traditional Chinese Medicine |
||
|
研究负责人所在单位: |
上海市中医医院 |
||
|
Affiliation of the Leader: |
Shanghai Municipal Hospital of Traditional Chinese Medicine |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2023SHL-KY-85-01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
上海市中医医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Shanghai Municipal Hospital of Traditional Chinese Medicine |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-07-05 00:00:00 | ||
|
伦理委员会联系人: |
凌丽 |
||
|
Contact Name of the ethic committee: |
Li Ling |
||
|
伦理委员会联系地址: |
上海市静安区芷江中路274号 |
||
|
Contact Address of the ethic committee: |
274 Zhijiang Middle Road, Jing'an District, Shanghai, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 21 5662 8310 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
上海市中医医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Shanghai Municipal Hospital of Traditional Chinese Medicine |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
上海市静安区芷江中路274号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
274 Zhijiang Middle Road, Jing'an District, Shanghai, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹 |
||||||||||||||||||||||
|
Source(s) of funding: |
self-financing |
||||||||||||||||||||||
|
研究疾病: |
神经根型颈椎病 |
||||||||||||||||||||||
|
Target disease: |
cervical spondylotic radiculopathy |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
回顾性研究 | ||||||||||||||||||||||
|
Study phase: |
Retrospective study |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
评价经皮等离子椎间盘减压术(PPDD)和脉冲射频术(PRF)通过下颈椎入路在治疗上肢根性疼痛、改善颈椎功能的同时,缓解上颈椎病变引起的颈源性头痛症状的有效性。 |
||||||||||||||||||||||
|
Objectives of Study: |
To evaluate the effectiveness of percutaneous plasma disc decompression (PPDD) and pulse radiofrequency(PRF) for relieving cervicogenic headache symptoms caused by upper cervical spine lesions through a lower cervical surgical approach ,while treating upper extremity radicular pain and improving cervical function. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1. 入院诊断为神经根型颈椎病且入院病史中颈椎症状及上肢症状明确。. 2. 主要体征和症状是单侧神经根性颈肩臂痛、上肢及手部的疼痛麻木等。 3. CT、MRI等检查显示,有颈椎间盘突出导致神经根受压的迹象。 4. 手术记录的治疗靶点为C5-C8颈神经(行PRF术)或C4-C7颈椎间盘(行PPDD术)。 5. 患者在社会心理学,精神、身体等层面上完全遵循本协议,包括遵循预定的访问,能完成理解量表内容。 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Admission diagnosis was cervical spondylotic radiculopathy with clear cervical and upper extremity symptoms in the admission history. 2. The main signs and symptoms were unilateral radicular pain, pain and numbness in the upper limbs and hands, etc. 3. CT and MRI of the cervical spine showed signs of nerve root compression due to cervical disc herniation. 4. The surgically documented therapeutic target is the C5-C8 nerve root (PRF) or C4-C7 disc (PPDD). 5. The patient is fully compliant with this protocol at the psychosocial, mental, and physical levels, including following scheduled visits and understanding the content of the scale. |
||||||||||||||||||||||
|
排除标准: |
1.合并游离椎间盘、严重椎管狭窄和纤维环钙化、后纵韧带骨化、腕管综合征、肩周炎。 2.合并截瘫或部分瘫痪、颈椎骨折或脱位、颈椎不稳。 3.在计划手术阶段有手术史,无法忍受治疗过程或有手术禁忌症。 4. 有明显社会心理疾病,沟通障碍的患者 5. 经研究者评估其他不适合参与研究的患者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Combination of free disc, severe spinal stenosis and calcification of the fibrous annulus, ossification of the posterior longitudinal ligament, carpal tunnel syndrome, and frozen shoulder. 2. Combination of paraplegia or partial paralysis, cervical fracture or dislocation, and cervical instability. 3.History of surgery during the planned surgical phase, inability to tolerate the course of treatment or contraindications to surgery. 4. Patients with significant psychosocial disorders, communication disorders. 5.Other patients assessed by the investigator as unsuitable for participation. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-06-01 00:00:00至 To 2023-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-08-01 00:00:00 至 To 2023-09-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
我们通过CRF表以及病案检索系统对患者病例信息进行采集和管理。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
We collected and managed patients' case information through CRF forms as well as Medical record retrieval. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |